http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20061832-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a25274019bd93e10ed15f781f6c4adf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57ed2c163c460e1330d532a597c7e01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a5a8db2304fbcca031036b3fc9985b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12c114d071b81d633d8aa1167dbddf71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a9a7229953746cff4a8d8ee85561ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_597d50c001e3f3f067e695a3f50861dc
publicationDate 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20061832-L
titleOfInvention Carbamide derivatives of amide type
abstract Amide type carboxamide derivatives of general formula [1]: wherein X is -N = or -CH =; R 1 is halogen, lower alkyl, etc; R 2 has the formula [2] Y 1 and Y 2 are the same or different and are halogen or a group selected from lower alkyl, lower alkoxy, etc .; and ring A is phenyl etc. Pharmacologically acceptable salts of the derivative are also described. The derivative and salts are useful as medicine, especially as an FXa inhibitor. where X is -N = or -CH =; R 1 is halogen, lower alkyl, etc; R 2 has the formula [2] Y 1 and Y 2 are the same or different and are halogen or a group selected from lower alkyl, lower alkoxy, etc .; and ring A is phenyl etc. Pharmacologically acceptable salts of the derivative are also described. The derivative and salts are useful as medicine, especially as an FXa inhibitor.
priorityDate 2003-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 29.